CCR5 Antagonist TD-0680 Uses a Novel Mechanism for Enhanced Potency against HIV-1 Entry, Cell-mediated Infection, and a Resistant VariantYuanxi Kang, Zhiwei Chen, Terrence Chi‐Kong Lau et al.|Journal of Biological Chemistry|2012Cited by 17